107 related articles for article (PubMed ID: 32516473)
1. Vascular endothelial growth factor (VEGF) and Endocrine gland-VEGF (EG-VEGF) are down regulated in head and neck cancer.
Bouzoubaa SM; Benlahfid M; Sidqui M; Aboussaouira T; Rifki C; Brouillet S; Traboulsi W; Alfaidy N; Benharouga M
Clin Otolaryngol; 2020 Sep; 45(5):788-795. PubMed ID: 32516473
[TBL] [Abstract][Full Text] [Related]
2. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis.
Benlahfid M; Traboulsi W; Sergent F; Benharouga M; Elhattabi K; Erguibi D; Karkouri M; Elattar H; Fadil A; Fahmi Y; Aboussaouira T; Alfaidy N
Cancer Biomark; 2018 Feb; 21(2):345-354. PubMed ID: 29226856
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of endocrine gland-derived vascular endothelial growth factor but not vascular endothelial growth factor in human ectopic endometriotic tissue.
Lee KF; Lee YL; Chan RW; Cheong AW; Ng EH; Ho PC; Yeung WS
Fertil Steril; 2010 Mar; 93(4):1052-60. PubMed ID: 19135668
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of EG-VEGF-mediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells.
Brouillet S; Hoffmann P; Benharouga M; Salomon A; Schaal JP; Feige JJ; Alfaidy N
Mol Biol Cell; 2010 Aug; 21(16):2832-43. PubMed ID: 20587779
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression
Traboulsi W; Sergent F; Boufettal H; Brouillet S; Slim R; Hoffmann P; Benlahfid M; Zhou QY; Balboni G; Onnis V; Bolze PA; Salomon A; Sauthier P; Mallet F; Aboussaouira T; Feige JJ; Benharouga M; Alfaidy N
Clin Cancer Res; 2017 Nov; 23(22):7130-7140. PubMed ID: 28899975
[No Abstract] [Full Text] [Related]
6. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
[TBL] [Abstract][Full Text] [Related]
7. Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition.
Dunand C; Hoffmann P; Sapin V; Blanchon L; Salomon A; Sergent F; Benharouga M; Sabra S; Guibourdenche J; Lye SJ; Feige JJ; Alfaidy N
Biol Reprod; 2014 Sep; 91(3):73. PubMed ID: 25122063
[TBL] [Abstract][Full Text] [Related]
8. Gene-gene interactions and risk of recurrent miscarriages in carriers of endocrine gland-derived vascular endothelial growth factor and prokineticin receptor polymorphisms.
Su MT; Lin SH; Chen YC; Kuo PL
Fertil Steril; 2014 Oct; 102(4):1071-1077.e3. PubMed ID: 25064403
[TBL] [Abstract][Full Text] [Related]
9. Effect of high ovarian response on the expression of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in peri-implantation endometrium in IVF women.
Xu LZ; Gao MZ; Yao LH; Liang AJ; Zhao XM; Sun ZG
Int J Clin Exp Pathol; 2015; 8(8):8902-11. PubMed ID: 26464631
[TBL] [Abstract][Full Text] [Related]
10. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.
Hoffmann P; Feige JJ; Alfaidy N
Placenta; 2007 Oct; 28(10):1049-58. PubMed ID: 17531315
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor.
Goi T; Fujioka M; Satoh Y; Tabata S; Koneri K; Nagano H; Hirono Y; Katayama K; Hirose K; Yamaguchi A
Cancer Res; 2004 Mar; 64(6):1906-10. PubMed ID: 15026321
[TBL] [Abstract][Full Text] [Related]
12. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical expression of endocrine gland-derived-VEGF (EG-VEGF) as a prognostic marker in ovarian cancer.
Bălu S; Pirtea L; Gaje P; Cîmpean AM; Raica M
Rom J Morphol Embryol; 2012; 53(3):479-83. PubMed ID: 22990536
[TBL] [Abstract][Full Text] [Related]
14. PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development.
Garnier V; Traboulsi W; Salomon A; Brouillet S; Fournier T; Winkler C; Desvergne B; Hoffmann P; Zhou QY; Congiu C; Onnis V; Benharouga M; Feige JJ; Alfaidy N
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E357-69. PubMed ID: 26081281
[TBL] [Abstract][Full Text] [Related]
15. Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers.
Baruah P; Lee M; Wilson PO; Odutoye T; Williamson P; Hyde N; Kaski JC; Dumitriu IE
Br J Cancer; 2015 Aug; 113(4):653-9. PubMed ID: 26171937
[TBL] [Abstract][Full Text] [Related]
16. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.
Hoffmann P; Feige JJ; Alfaidy N
Endocrinology; 2006 Apr; 147(4):1675-84. PubMed ID: 16384869
[TBL] [Abstract][Full Text] [Related]
17. Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells.
Kisliouk T; Levy N; Hurwitz A; Meidan R
J Clin Endocrinol Metab; 2003 Aug; 88(8):3700-7. PubMed ID: 12915658
[TBL] [Abstract][Full Text] [Related]
18. Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors.
Heck D; Wortmann S; Kraus L; Ronchi CL; Sinnott RO; Fassnacht M; Sbiera S
Horm Cancer; 2015 Dec; 6(5-6):225-36. PubMed ID: 26475302
[TBL] [Abstract][Full Text] [Related]
19. Endocrine gland derived-VEGF is down-regulated in human pituitary adenoma.
Raica M; Coculescu M; Cimpean AM; Ribatti D
Anticancer Res; 2010 Oct; 30(10):3981-6. PubMed ID: 21036711
[TBL] [Abstract][Full Text] [Related]
20. EG-VEGF, BV8, and their receptor expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508).
Chauvet S; Traboulsi W; Thevenon L; Kouadri A; Feige JJ; Camara B; Alfaidy N; Benharouga M
Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(3):L314-22. PubMed ID: 26047640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
